Hovione has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Membrane Technology

Membrane technology has evolved considerably in recent years making reliable and efficient purification or concentration technology more readily available to drug substance development. Hovione has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration to support manufacturing from lab to commercial scale.

Also in Drug Substance Capabilities

Chromatography

Hovione has expanded its purification technologies to include chromatography to support development from lab to commercial scale.

Page

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page

HPAPI – Highly Potent API

Our service for HPAPIs ranges from Drug Substance to Particle Engineering.

Page

Hydrogenations

Hovione has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.

Page

Cryogenics

Hovione has an abundance of experience in carrying out reactions at low temperatures.

Page